IRIS is typically observed in HIV/acquired immunodeficiency syndrome (AIDS) patients during the initial months of highly active antiretroviral therapy (HAART), where it is believed to result from an exaggerated immune response to opportunistic pathogens as CD4+ T cell counts recover [28]. The gene discussed is CD4; the disease is AIDS.